Study to Evaluate the Safety, Tolerability, and PK of Pacritinib

Clinical trial NCT05552183 · COMPLETED

Trial details

NCT number: NCT05552183
Sponsor: CTI BioPharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2022-12-12
Primary completion: 2024-06-10
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.